CLDN3 and cancer: Ligand‐receptor pairs (CLDN3‐CLDN3, CLDN11‐CLDN11, and PPIA‐BSG) associated with ECM‐related cell types (X3, X4) and cancer‐related cell types (X0, X1, and X2) within these pathways were identified and visualized (Figure 6k,l).